Drugs / Nitrous Oxide
last change 11 days ago re-read 9 days ago

Nitrous Oxide

Other / unclassified

Developed for
major depressive disorder · anxiety · abscess · cognitive disorder · depressive disorder · post-traumatic stress disorder · sickle cell disease · bipolar depression
+12 more · frozen shoulder · mental disorder · migraine disorder · neuropathy, painful · obsessive-compulsive disorder · tinnitus · anxiety disorder · bipolar disorder · cardiac valvular defect · complex regional pain syndrome · fibromyalgia · intermittent explosive disorder
Investigated by
Washington University School of Medicine · Albert Einstein Healthcare Network · University Hospital, Clermont-Ferrand · University Hospital, Tours · Air Liquide · Austin Health
+92 more · Bayside Health · Brain & Behavior Research Foundation · Columbia University · French National Institute of Health and Medical Research · Hospices Civils de Lyon · National Institute on Drug Abuse (NIDA) · Stanford University · Tel-Aviv Sourasky Medical Center · The Cleveland Clinic · Unity Health Toronto · University of Chicago · University of Colorado, Denver · Université d'Auvergne · Alexandra J. Berger Eberhardt, MD · American Foundation for Suicide Prevention · Anesthesia Clinical Trials Unit (Department of Anesthesia and Pain Management) · Assistance Publique - Hôpitaux de Paris · Australia: Theapeutic Goods Administration · Baxter Healthcare Corporation · Baylor Research Institute · Beth Israel Deaconess Medical Center · Bnai Zion Medical Center · Bon Secours Pediatric Dental Associates · Boston Children's Hospital · Canadian Institutes of Health Research (CIHR) · Children's Hospital Colorado · Children's Hospitals and Clinics of Minnesota · Czech Technical University in Prague · Emergency Medicine Foundation · Faculty Sao Leopoldo Mandic Campinas · Fluminense Federal University · Foundation for Anesthesia Education and Research · Francisco Groppo · Geisinger Clinic · Hopital Foch · Jefferson Drapkin · Keith M Vogt · L'effet Papillon · La Trobe University · Latakia University · Lingjiang Li · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Maisonneuve-Rosemont Hospital · Medical University of Vienna · Ministry of Health, France · Monash University · Nantes University Hospital · National Health and Medical Research Council, Australia · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · National Institute of General Medical Sciences (NIGMS) · National Institute of Mental Health (NIMH) · New York City Health and Hospitals Corporation · Nîmes University Hospital · Oregon Health and Science University · PPD Development, LP · Poitiers University Hospital · Praxair Distribution, Inc. · Research to Prevent Blindness · Rikshospitalet University Hospital · Robert L. Bacon Medical Foundation · Seoul National University Hospital · Shaoxing Maternity and Child Health Care Hospital · Sheba Medical Center · Society of Family Planning · Southern California Institute for Research and Education · Stanley Medical Research Institute · Sunnybrook Health Sciences Centre · Tampere University · Tampere University Hospital · The Alfred · TriHealth Inc. · University Health Network, Toronto · University Hospital, Bordeaux · University of Arizona · all 98 on the full record

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) NITROUS OXIDE, USP — 2013-06-16 fda.gov ↗

Trials 82 · started per year

today
US approved 2013
2
1
2
2
4
1
2
5
1
1
5
5
3
1
7
6
4
7
7
2
3
3
3
4
19971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 08 trials
Phase 0 NCT07245628 Oct 2025 → May 2028 expected — Alexandra J. Berger Eberhardt, MD Recruiting No outcome recorded
Phase 0 NCT06702631 Jan 2025 → Sep 2026 overdue amnestic disorder Keith M Vogt Recruiting No outcome recorded
Phase 0 NCT05579288 Dec 2022 → Jun 2024 — Sheba Medical Center Unknown No outcome recorded
Phase 0 NCT04305158 Mar 2022 → Aug 2023 — University of Arkansas Completed No outcome recorded
Phase 0 NCT06661005 May → Sep 2021 — University of Arizona Terminated No outcome recorded
Phase 0 NCT03695887 Oct 2019 → Dec 2028 expected — University of Manitoba Recruiting No outcome recorded
Phase 0 NCT02757521 Mar → Dec 2016 bipolar depression Washington University School of Medicine Terminated No outcome recorded Stop: Enrollment
Phase 0 NCT02246517 Sep 2014 → Dec 2015 neuropathy, painful Tel-Aviv Sourasky Medical Center Unknown No outcome recorded
Phase 15 trials
Phase 1 NCT04884893 May → Sep 2021 — Tampere University Hospital Completed No outcome recorded
Phase 1 NCT03736538 Oct 2018 → Sep 2026 overdue major depressive disorder Washington University School of Medicine Enrolling by invitation No outcome recorded
Phase 1 NCT02994433 Jan 2017 → Apr 2027 expected major depressive disorder Washington University School of Medicine Recruiting No outcome recorded
Phase 1 NCT01785030 Feb 2013 → Feb 2017 — Columbia University Terminated No outcome recorded Stop: Enrollment
Phase 1 NCT01736020 Sep 2009 → Apr 2017 — Southern California Institute for Research and Education Unknown No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT02899182 Apr 2016 → Mar 2017 — Fluminense Federal University Completed No outcome recorded
Phase 214 trials · 1 missed
Phase 2 NCT06382389 Sep 2026 → Sep 2028 expected cognitive disorder, depressive disorder University Hospital, Tours Not yet recruiting No outcome recorded
Phase 2 NCT06636357 Jan 2025 → Sep 2026 overdue electroencephalographic peculiarity: fronto-precentral beta wave groups, hair anomaly University of Zurich Recruiting No outcome recorded
Phase 2 NCT06430489 Jun 2024 → Dec 2025 — University Hospital, Tours Unknown No outcome recorded
Phase 2 NCT07384988 Jan → Aug 2024 — Shaoxing Maternity and Child Health Care Hospital Completed No outcome recorded
Phase 2 NCT04378426 Oct 2021 → Aug 2022 post-traumatic stress disorder VA Office of Research and Development Terminated No outcome recorded
Phase 2 NCT03826693 Apr 2021 → Sep 2026 overdue obsessive-compulsive disorder Stanford University Recruiting No outcome recorded
Phase 2 NCT03932825 Apr 2019 → Mar 2021 major depressive disorder Lingjiang Li Completed No outcome recorded
Phase 2 NCT03869736 Jan 2019 → Jun 2023 major depressive disorder Bayside Health Completed No outcome recorded
Phase 2 NCT03375294 Apr 2018 → Jul 2019 post-traumatic stress disorder Stanford University Completed No outcome recorded
Phase 2 NCT03283670 Nov 2016 → Feb 2020 major depressive disorder Washington University School of Medicine Completed Missed primary
Phase 2/33 trials · 1 missed
Phase 2/3 NCT04089852 Jun → Nov 2021 — Boston Children's Hospital Withdrawn No outcome recorded
Phase 2/3 NCT03483194 Sep 2018 → Apr 2020 hematopoietic and lymphoid cell neoplasm Weprom Completed Missed primary
Phase 2/3 NCT00762372 Feb → Aug 2008 — Baxter Healthcare Corporation Completed No outcome recorded
Phase 310 trials · 1 missed
Phase 3 NCT06498908 Mar 2026 — Jefferson Drapkin Withdrawn No outcome recorded
Phase 3 NCT07262008 Feb 2026 → Feb 2027 expected major depressive disorder Women's College Hospital Not yet recruiting No outcome recorded
Phase 3 NCT05383495 Dec 2023 → Dec 2025 overdue — London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Recruiting No outcome recorded
Phase 3 NCT03728894 Nov 2018 → Jan 2019 — Latakia University Completed No outcome recorded
Phase 3 NCT03502915 Jan 2017 → Feb 2019 — University of North Carolina, Chapel Hill Completed No outcome recorded
Phase 3 NCT01948115 Nov 2013 → Dec 2015 — Nantes University Hospital Completed Missed primary
Phase 3 NCT00643357 Mar 2008 → Jan 2009 — Air Liquide Withdrawn No outcome recorded Stop: Enrollment
Phase 3 NCT00392522 Nov 2006 → ? — Hospices Civils de Lyon Unknown No outcome recorded
Phase 3 NCT00219713 Mar 2000 → Dec 2004 — Poitiers University Hospital Terminated No outcome recorded
Phase 3 NCT00250692 — — University of California, Los Angeles Withdrawn No outcome recorded
Phase 422 trials · 1 met primary · 3 missed
Phase 4 NCT07387315 Feb → Nov 2026 expected overactive bladder TriHealth Inc. Not yet recruiting No outcome recorded
Phase 4 NCT05895383 May 2023 → Jan 2027 expected anxiety Beth Israel Deaconess Medical Center Recruiting No outcome recorded
Phase 4 NCT04957368 Nov 2021 → Feb 2024 major depressive disorder Unity Health Toronto Completed No outcome recorded
Phase 4 NCT03941990 Nov 2019 → Apr 2020 anxiety University Hospital, Clermont-Ferrand Unknown No outcome recorded
Phase 4 NCT04083105 Jul 2019 → Jul 2021 — Children's Hospital Colorado Unknown No outcome recorded
Phase 4 NCT03847922 Feb 2019 → Jul 2020 female stress incontinence Baylor Research Institute Terminated No outcome recorded
Phase 4 NCT03228628 Oct 2017 → Jun 2018 anxiety University Hospital, Clermont-Ferrand Unknown No outcome recorded
Phase 4 NCT03435055 Jul 2017 → Oct 2019 — University of Michigan Completed No outcome recorded
Phase 4 NCT02985697 Jan 2017 → Jan 2018 — Bon Secours Pediatric Dental Associates Unknown No outcome recorded
Phase 4 NCT03365011 Oct 2016 → Jun 2017 tinnitus Washington University School of Medicine Completed Missed primary
Phase not applicable19 trials · 1 met primary
— NCT06557642 Jul 2024 → Aug 2025 overdue depressive disorder University of Oxford Recruiting No outcome recorded
— NCT05890898 Sep 2023 → Jul 2024 — Geisinger Clinic Completed No outcome recorded
— NCT05007028 Nov 2021 → Dec 2024 mental disorder University Hospital, Tours Completed Met primary
— NCT04050267 Apr 2019 poisoning Czech Technical University in Prague Completed No outcome recorded
— NCT02886351 Jan 2017 → Jan 2018 anxiety Bnai Zion Medical Center Unknown No outcome recorded
— NCT03127371 Sep 2016 → Apr 2021 abscess Albert Einstein Healthcare Network Terminated No outcome recorded Stop: Enrollment
— NCT02755090 Jul 2016 → May 2017 — University of New Mexico Completed No outcome recorded
— NCT02410707 Feb 2015 → Feb 2018 abscess Albert Einstein Healthcare Network Completed No outcome recorded
— NCT01616004 Oct 2014 → Aug 2015 — Tel-Aviv Sourasky Medical Center Unknown No outcome recorded
— NCT02145169 Oct 2013 → Apr 2016 — Albert Einstein Healthcare Network Completed No outcome recorded
Comparator or background therapy64 trials
Phase 0 NCT03165500 Comparator Dec 2015 → Dec 2016 anxiety disorder São Paulo State University Completed No outcome recorded
Phase 1 NCT06867068 Comparator Oct 2016 → Jun 2024 — Albert Einstein College of Medicine Completed No outcome recorded
Phase 1 NCT01581450 Comparator Jan → Apr 2012 — Air Liquide Completed No outcome recorded
Phase 2 NCT05710887 Comparator Feb 2026 major depressive disorder University of Chicago Withdrawn No outcome recorded
Phase 2 NCT06118567 Comparator Sep 2022 → Aug 2027 expected intermittent explosive disorder Ohio State University Recruiting No outcome recorded

Evidence & citations 8 cited values

Every value below carries the sentence it was read from. 151 sources stand behind the page.

FieldValueCited text
Known as nitrous oxide “Nitrous oxide inhalation was preferable to injectable ketamine for pediatric patients because it is safe, allows for a faster recovery, maintains sufficient sedation time, and...” PMID 23187987 ↗ Dec 2012
137

“Nitrous oxide (N2O) has been used since the 19th century for its analgesic, antinociceptive and anxiolytic effects during surgical procedures in awake and anaesthetised patients.” PMID 33399383 ↗ May 2021

“All patients will receive injectable paracetamol for pain relief, a mix of nitrous oxide 50% and oxygen 50% for analgesia and lidocaine hydrochloride for local anesthesia.” NCT02236260 ↗

“Anesthesia is maintained by 1-1.5% sevoflurane, 0.5 µg/kg/h fentanyl, 0.05 mg/kg/h nimbex, 60% nitrous oxide and 40% oxygen.” NCT02534012 ↗

“The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide.” NCT00000250 ↗

“The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide.” NCT00000257 ↗

“The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide.” NCT00000253 ↗

“The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide.” NCT00000249 ↗

“The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide.” NCT00000256 ↗

“Nitrous oxide, an inhalant agent used extensively In anesthesia, also have antagonist property of NMDA receptors.” NCT02246517 ↗

“administeration via inhalation of Nitrous oxide/oxygen (30-50% N2O/ 70-50% O2) via inhalation” NCT05126459 ↗

Show 127 more sources

Known as laughing gas “Nitrous oxide, commonly known as laughing gas, is a colorless, non-flammable gas with a slightly sweet odor, used for its analgesic and anesthetic properties in medical and...” NCT06498908 ↗
2

“There are some compelling reasons to question the routine use of nitrous oxide (N2O), also known as "laughing gas".” NCT00164047 ↗

“Inhalation of Nitrous oxide (Laughing gas) + intravenous saline” NCT07262008 ↗

Known as N2O “Patients receive inhaled nitrous oxide (N₂O) administered through a buccal-nasal mask starting approximately 5 minutes before the outpatient hysteroscopy procedure and...” NCT07473206 ↗
38

“Nitrous oxide (N(2)O) has the advantages of being a sedative agent that does not require a painful injection and that offers shallower levels of sedation and a rapid recovery...” PMID 23187987 ↗ Dec 2012

“Women were assigned according to a balanced (1:1) restricted randomization design to inhale either nitrous oxide (N2 O) in a 50:50 mix with oxygen or medical air during the procedure.” PMID 31630398 ↗ Nov 2019

“Nitrous oxide (N2O) may offer a new therapeutic avenue with rapid and safe antidepressant effects in late-life depression with inadequate antidepressant response.” PMID 42005916 ↗ Apr 2026

“an alternative method of providing analgesia with "on-demand" inhalation of nitrous oxide (hereafter referred to as N2O) combined with oxygen has been postulated.” NCT04305158 ↗

“Nitrous oxide (N2O) is used as an inhalative gas during anesthesia, labour and at some dentist practices, most frequent in a fixed 50:50 combination with O2.” NCT00318825 ↗

“different concentrations of nitrous oxide (N2O) have different antidepressant effects for adults with treatment-resistant major depression.” NCT03283670 ↗

“This study aims at investigating the persistence of antidepressant effect of Nitrous Oxide (N2O) for Treatment-Resistant Depression(TRD).” NCT03932825 ↗

“This study is designed to evaluate the analgesic effect of nitrous oxide (N2O) on the pain induced during lumbar puncture.” NCT02243826 ↗

“Several lines of reasoning suggest that nitrous oxide (N2O) is an ideal medication to study as a potential treatment” PMID 32637725 ↗ Jun 2020

“Nitrous oxide (N2O) is a gas that is normally used to take away pain and anxiety during painful medical procedures.” NCT01785030 ↗

Show 28 more sources

Known as Nitrous Oxide + Oxygen Gas ClinicalTrials.gov intervention name — accepted as the source's own label NCT03847922 ↗
Known as SANO “Whether self-administered low dose (20-45%) nitrous oxide (SANO) reduces intraoperative anxiety and catastrophizing during office vasectomy.” NCT07245628 ↗
Action Inhibit “N2O inhibits vitamin B12-dependent enzymes” NCT00655980 ↗
Modality Other / unclassified “Nitrous oxide (N2O) is a gas that is normally used to take away pain and anxiety during painful medical procedures.” NCT01785030 ↗
Route Inhaled “20% inhaled N2O” NCT00000249 ↗